The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.
about
Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug TargetsCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementRomidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataRomidepsin: in the treatment of T-cell lymphoma.Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.Vorinostat-An Overview.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Histone deacetylase inhibitors in the generation of the anti-tumour immune response.HDAC inhibitors for the treatment of cutaneous T-cell lymphomas.Cutaneous T cell lymphoma: update on treatment.Current trends in epigenetic drug discovery.Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.NFκB function and regulation in cutaneous T-cell lymphoma.The discovery and development of romidepsin for the treatment of T-cell lymphoma.Medicinal significance of naturally occurring cyclotetrapeptides.Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γImmune effectors required for the therapeutic activity of vorinostat.Novel treatment opportunities for sulfur mustard-related cancers: genetic and epigenetic perspectives.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.HDAC Inhibition Improves the Sarcoendoplasmic Reticulum Ca2+-ATPase Activity in Cardiac Myocytes.Suppression of IL-12p40-related regulatory cytokines by suberoylanilide hydroxamic acid an inhibitor of histone deacetylases.Effect of a Histone Deacetylases Inhibitor of IL-18 and TNF-Alpha Secretion in Vitro.Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
P2860
Q26750964-BA0507F4-833B-46AC-9FF3-87A0C39B83F3Q27024076-F0723AFE-44DD-4FFF-803A-7C07C5717CF9Q30936712-0630973D-8D12-4EF4-99BF-681424DF0A30Q33396519-D40D3E26-6584-462A-82A8-DE8680E2A0E8Q33612118-423A6806-1B7C-4ED0-BDB8-2D6DA0519708Q35944176-A38A86F3-D2D5-4D53-AB4C-91EA72E4FCD9Q36470196-F912CE6E-12C0-4A7D-AB17-D37522506123Q36974344-2CF72D26-B61F-4362-9438-F451DF38330FQ37944565-77182A44-E903-4E5A-9E06-6D4FD7C224B7Q37953826-02D0A9D3-2963-4667-9266-D7B41D842B68Q37993586-B3221B9D-80BB-4988-B4EC-148DA341E424Q38036396-D50FADDE-E993-4511-A538-F8B362ED175AQ38060183-EEB49383-1BB8-4279-96CC-8BBC224B8F5CQ38139309-27C55A11-E64A-4C3A-8676-EA8B476702C5Q38162229-9E5A79DC-67E1-4E69-8F27-F572C5AE12E5Q38713744-915C8E0C-C98C-4360-90B0-6E59DA2DD53FQ38853326-A16024FB-4ABD-4F94-906C-7EB17AD549C6Q38906418-98677A84-CD71-45A7-8427-A7F979887E48Q39150343-DCC32AF5-F758-4FDA-8623-922760F84B28Q39339685-6528BA48-F6B1-44BA-919B-79CB034E8FDAQ41871572-ED6ADE21-90D8-4316-AEC1-D163B277BC66Q45873027-AE01CDCF-0344-4ABD-B953-5AE705642116Q48034709-5B68554A-AEFF-4098-93FD-E5E6E2E05522Q48134207-D4BE7758-89D9-4FC6-942C-5B2D24325E10Q51729809-E7FF7C5C-7292-47EF-BD92-860BD3684276Q52727010-2031B735-7A62-44AB-B58B-9E94B8BA686FQ53169048-0ABC9388-6C33-4F7A-8755-09F3EFD2DC76
P2860
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@ast
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@en
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@nl
type
label
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@ast
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@en
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@nl
prefLabel
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@ast
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@en
The histone deacetylase inhibi ...... taneous T-cell lymphoma cells.
@nl
P2093
P2860
P50
P1476
The histone deacetylase inhibi ...... utaneous T-cell lymphoma cells
@en
P2093
L van der Fits
Mh Vermeer
Pa Townsend
P2860
P304
P356
10.1111/J.1476-5381.2010.01188.X
P407
P577
2011-04-01T00:00:00Z